{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:06:42Z","timestamp":1771952802003,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mechanisms underlying the renal pathology in cardiorenal syndrome (CRS) type 2 remain elusive. We hypothesised that renal glutathione deficiency is central to the development of CRS type 2. Glutathione precursor, N-acetylcysteine (NAC;40\u2009mg\/kg\/day; 8 weeks) or saline were administered to transgenic mice with dilated cardiomyopathy (DCM) and wild-type (WT) controls. Cardiac structure, function and glutathione levels were assessed at the end of this protocol. Renal fibrosis, glutathione content, expression of inflammatory and fibrotic markers, and function were also evaluated. In both genotypes, NAC had minimal effect on cardiac glutathione, structure and function (<jats:italic>P<\/jats:italic>\u2009\u2265\u20090.20). In NAC treated DCM mice, loss of glomerular filtration rate (GFR), tubulointerstitial and glomerular fibrosis and renal oxidised glutathione levels were attenuated by 38%, 99%, 70% and 52% respectively, compared to saline treated DCM mice (<jats:italic>P<\/jats:italic>\u2009\u2264\u20090.01). Renal expression of PAI-1 was greater in saline treated DCM mice than in WT mice (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Renal PAI-1 expression was less in NAC treated DCM mice than in vehicle treated DCM mice (<jats:italic>P<\/jats:italic>\u2009=\u20090.03). Renal IL-10 expression was greater in the former cohort compared to the latter (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.01). These data indicate that normalisation of renal oxidized glutathione levels attenuates PAI-1 expression and renal inflammation preventing loss of GFR in experimental DCM.<\/jats:p>","DOI":"10.1038\/s41598-017-17927-5","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T11:58:07Z","timestamp":1513079887000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["N-Acetylcysteine Attenuates\u00a0the Development of Renal Fibrosis in Transgenic Mice with Dilated Cardiomyopathy"],"prefix":"10.1038","volume":"7","author":[{"given":"Beverly","family":"Giam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjaya","family":"Kuruppu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Yin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Ian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine Z.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"April","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan","family":"Horlock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Kiriazis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Jun","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niwanthi W.","family":"Rajapakse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"key":"17927_CR1","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/CIRCULATIONAHA.109.192667","volume":"121","author":"M Writing Group","year":"2010","unstructured":"Writing Group, M. et al. Heart disease and stroke statistics\u20132010 update: a report from the American Heart Association. Circulation \n                           121, e46\u2013e215, https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.192667 (2010).","journal-title":"Circulation"},{"key":"17927_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger, V. L. Epidemiology of heart failure. Circ Res \n                           113, 646\u2013659, https:\/\/doi.org\/10.1161\/CIRCRESAHA.113.300268 (2013).","journal-title":"Circ Res"},{"key":"17927_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.hlc.2016.02.022","volume":"25","author":"B Giam","year":"2016","unstructured":"Giam, B., Kaye, D. M. & Rajapakse, N. W. Role of Renal Oxidative Stress in the Pathogenesis of the Cardiorenal Syndrome. Heart Lung Circ \n                           25, 874\u2013880, https:\/\/doi.org\/10.1016\/j.hlc.2016.02.022 (2016).","journal-title":"Heart Lung Circ"},{"key":"17927_CR4","doi-asserted-by":"publisher","first-page":"920195","DOI":"10.4061\/2011\/920195","volume":"2011","author":"BN Shah","year":"2010","unstructured":"Shah, B. N. & Greaves, K. The cardiorenal syndrome: a review. Int J Nephrol \n                           2011, 920195, https:\/\/doi.org\/10.4061\/2011\/920195 (2010).","journal-title":"Int J Nephrol"},{"key":"17927_CR5","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"ES Chung","year":"2003","unstructured":"Chung, E. S. et al. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation \n                           107, 3133\u20133140, https:\/\/doi.org\/10.1161\/01.CIR.0000077913.60364.D2 (2003).","journal-title":"Circulation"},{"key":"17927_CR6","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","volume":"109","author":"DL Mann","year":"2004","unstructured":"Mann, D. L. et al. Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation \n                           109, 1594\u20131602, https:\/\/doi.org\/10.1161\/01.CIR.0000124490.27666.B2 (2004).","journal-title":"Circulation"},{"key":"17927_CR7","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1089\/152308601300185269","volume":"3","author":"P Renard","year":"2001","unstructured":"Renard, P., Delaive, E., Van Steenbrugge, M., Remacle, J. & Raes, M. Is the effect of interleukin-1 on glutathione oxidation in cultured human fibroblasts involved in nuclear factor-kappaB activation? Antioxid Redox Signal \n                           3, 329\u2013340, https:\/\/doi.org\/10.1089\/152308601300185269 (2001).","journal-title":"Antioxid Redox Signal"},{"key":"17927_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1172\/JCI115658","volume":"89","author":"Y Ishii","year":"1992","unstructured":"Ishii, Y., Partridge, C. A., Del Vecchio, P. J. & Malik, A. B. Tumor necrosis factor-alpha-mediated decrease in glutathione increases the sensitivity of pulmonary vascular endothelial cells to H2O2. The Journal of clinical investigation \n                           89, 794\u2013802, https:\/\/doi.org\/10.1172\/JCI115658 (1992).","journal-title":"The Journal of clinical investigation"},{"key":"17927_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00580-016-2248-7","volume":"25","author":"K Piyarungsri","year":"2016","unstructured":"Piyarungsri, K. & Pusoonthornthum, R. Changes in reduced glutathione, oxidized glutathione, and glutathione peroxidase in cats with naturally occurring chronic kidney disease. Comparative Clinical Pathology \n                           25, 655\u2013662, https:\/\/doi.org\/10.1007\/s00580-016-2248-7 (2016).","journal-title":"Comparative Clinical Pathology"},{"key":"17927_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2009.09.026","volume":"48","author":"RM Liu","year":"2010","unstructured":"Liu, R. M. & Gaston Pravia, K. A. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis. Free Radic Biol Med \n                           48, 1\u201315, https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.09.026 (2010).","journal-title":"Free Radic Biol Med"},{"key":"17927_CR11","doi-asserted-by":"publisher","first-page":"L937","DOI":"10.1152\/ajplung.00150.2005","volume":"289","author":"PK Vayalil","year":"2005","unstructured":"Vayalil, P. K., Olman, M., Murphy-Ullrich, J. E., Postlethwait, E. M. & Liu, R. M. Glutathione restores collagen degradation in TGF-beta-treated fibroblasts by blocking plasminogen activator inhibitor-1 expression and activating plasminogen. Am J Physiol Lung Cell Mol Physiol \n                           289, L937\u2013945, https:\/\/doi.org\/10.1152\/ajplung.00150.2005 (2005).","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"17927_CR12","doi-asserted-by":"crossref","first-page":"C1391","DOI":"10.1152\/ajpcell.1999.276.6.C1391","volume":"276","author":"T Sakamoto","year":"1999","unstructured":"Sakamoto, T. et al. TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes. Am J Physiol \n                           276, C1391\u20131397 (1999).","journal-title":"Am J Physiol"},{"key":"17927_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-20","volume":"3","author":"M Romeu","year":"2010","unstructured":"Romeu, M. et al. Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study. BMC Res Notes \n                           3, 20, https:\/\/doi.org\/10.1186\/1756-0500-3-20 (2010).","journal-title":"BMC Res Notes"},{"key":"17927_CR14","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1093\/ndt\/gfq828","volume":"26","author":"A Crawford","year":"2011","unstructured":"Crawford, A. et al. Glutathione peroxidase, superoxide dismutase and catalase genotypes and activities and the progression of chronic kidney disease. Nephrol Dial Transplant \n                           26, 2806\u20132813, https:\/\/doi.org\/10.1093\/ndt\/gfq828 (2011).","journal-title":"Nephrol Dial Transplant"},{"key":"17927_CR15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/hr.2012.204","volume":"36","author":"X Chen","year":"2013","unstructured":"Chen, X. et al. Carbonyl stress induces hypertension and cardio-renal vascular injury in Dahl salt-sensitive rats. Hypertens Res \n                           36, 361\u2013367, https:\/\/doi.org\/10.1038\/hr.2012.204 (2013).","journal-title":"Hypertens Res"},{"key":"17927_CR16","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/ndt\/gfk032","volume":"21","author":"N Nitescu","year":"2006","unstructured":"Nitescu, N. et al. N-acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion. Nephrol Dial Transplant \n                           21, 1240\u20131247, https:\/\/doi.org\/10.1093\/ndt\/gfk032 (2006).","journal-title":"Nephrol Dial Transplant"},{"key":"17927_CR17","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/j.1523-1755.2005.00677.x","volume":"68","author":"MH Shimizu","year":"2005","unstructured":"Shimizu, M. H., Coimbra, T. M., de Araujo, M., Menezes, L. F. & Seguro, A. C. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int \n                           68, 2208\u20132217, https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00677.x (2005).","journal-title":"Kidney Int"},{"key":"17927_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/ki.2011.341","volume":"81","author":"JS Coombes","year":"2012","unstructured":"Coombes, J. S. & Fassett, R. G. Antioxidant therapy in hemodialysis patients: a systematic review. Kidney Int \n                           81, 233\u2013246, https:\/\/doi.org\/10.1038\/ki.2011.341 (2012).","journal-title":"Kidney Int"},{"key":"17927_CR19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3389\/fimmu.2015.00465","volume":"6","author":"TD Hewitson","year":"2015","unstructured":"Hewitson, T. D., Holt, S. G. & Smith, E. R. Animal Models to Study Links between Cardiovascular Disease and Renal Failure and Their Relevance to Human Pathology. Front Immunol \n                           6, 465, https:\/\/doi.org\/10.3389\/fimmu.2015.00465 (2015).","journal-title":"Front Immunol"},{"key":"17927_CR20","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1093\/ndt\/gft376","volume":"28","author":"E Cho","year":"2013","unstructured":"Cho, E. et al. Role of inflammation in the pathogenesis of cardiorenal syndrome in a rat myocardial infarction model. Nephrol Dial Transplant \n                           28, 2766\u20132778, https:\/\/doi.org\/10.1093\/ndt\/gft376 (2013).","journal-title":"Nephrol Dial Transplant"},{"key":"17927_CR21","doi-asserted-by":"publisher","first-page":"H1884","DOI":"10.1152\/ajpheart.00967.2011","volume":"302","author":"S Lekawanvijit","year":"2012","unstructured":"Lekawanvijit, S. et al. Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome. Am J Physiol Heart Circ Physiol \n                           302, H1884\u20131893, https:\/\/doi.org\/10.1152\/ajpheart.00967.2011 (2012).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"17927_CR22","doi-asserted-by":"publisher","first-page":"e47160","DOI":"10.1371\/journal.pone.0047160","volume":"7","author":"RE Gilbert","year":"2012","unstructured":"Gilbert, R. E. et al. A purpose-synthesised anti-fibrotic agent attenuates experimental kidney diseases in the rat. PLoS One \n                           7, e47160, https:\/\/doi.org\/10.1371\/journal.pone.0047160 (2012).","journal-title":"PLoS One"},{"key":"17927_CR23","doi-asserted-by":"crossref","first-page":"R730","DOI":"10.1152\/ajpregu.2001.281.3.R730","volume":"281","author":"EL Conesa","year":"2001","unstructured":"Conesa, E. L. et al. N-acetyl-L-cysteine improves renal medullary hypoperfusion in acute renal failure. Am J Physiol Regul Integr Comp Physiol \n                           281, R730\u2013737 (2001).","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"17927_CR24","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.ahj.2010.12.009","volume":"161","author":"S Ather","year":"2011","unstructured":"Ather, S. et al. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J \n                           161, 567\u2013573, https:\/\/doi.org\/10.1016\/j.ahj.2010.12.009 (2011).","journal-title":"Am Heart J"},{"key":"17927_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00392-008-0732-z","volume":"98","author":"TD Smilde","year":"2009","unstructured":"Smilde, T. D. et al. Differential associations between renal function and \u201cmodifiable\u201d risk factors in patients with chronic heart failure. Clin Res Cardiol \n                           98, 121\u2013129, https:\/\/doi.org\/10.1007\/s00392-008-0732-z (2009).","journal-title":"Clin Res Cardiol"},{"key":"17927_CR26","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajpath.2012.09.009","volume":"182","author":"CF Wu","year":"2013","unstructured":"Wu, C. F. et al. Transforming growth factor beta-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis. The American journal of pathology \n                           182, 118\u2013131, https:\/\/doi.org\/10.1016\/j.ajpath.2012.09.009 (2013).","journal-title":"The American journal of pathology"},{"key":"17927_CR27","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1111\/j.1523-1755.2005.00327.x","volume":"67","author":"S Matsuo","year":"2005","unstructured":"Matsuo, S. et al. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Kidney Int \n                           67, 2221\u20132238, https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00327.x (2005).","journal-title":"Kidney Int"},{"key":"17927_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/ki.1993.98","volume":"43","author":"IL Noronha","year":"1993","unstructured":"Noronha, I. L., Kr\u00fcger, C., Andrassy, K., Ritz, E. & Waldherr, R. In situ production of TNF-\u03b1, IL-1\u03b2 and IL-2R in ANCA-positive glomerulonephritis. Kidney International \n                           43, 682\u2013692, https:\/\/doi.org\/10.1038\/ki.1993.98 (1993).","journal-title":"Kidney International"},{"key":"17927_CR29","doi-asserted-by":"publisher","first-page":"189168","DOI":"10.1155\/2014\/189168","volume":"2014","author":"ZH Wang","year":"2014","unstructured":"Wang, Z. H., Ren, W. Y., Zhu, L. & Hu, L. J. Plasminogen activator inhibitor-1 regulates LPS induced inflammation in rat macrophages through autophagy activation. ScientificWorldJournal \n                           2014, 189168, https:\/\/doi.org\/10.1155\/2014\/189168 (2014).","journal-title":"ScientificWorldJournal"},{"key":"17927_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2016.06.005","volume":"177","author":"S Wrotek","year":"2016","unstructured":"Wrotek, S., Jedrzejewski, T., Piotrowski, J. & Kozak, W. N-Acetyl-l-cysteine exacerbates generation of IL-10 in cells stimulated with endotoxin in vitro and produces antipyresis via IL-10 dependent pathway in vivo. Immunol Lett \n                           177, 1\u20135, https:\/\/doi.org\/10.1016\/j.imlet.2016.06.005 (2016).","journal-title":"Immunol Lett"},{"key":"17927_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jconrel.2015.03.025","volume":"206","author":"CB Rodell","year":"2015","unstructured":"Rodell, C. B., Rai, R., Faubel, S., Burdick, J. A. & Soranno, D. E. Local immunotherapy via delivery of interleukin-10 and transforming growth factor beta antagonist for treatment of chronic kidney disease. J Control Release \n                           206, 131\u2013139, https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.025 (2015).","journal-title":"J Control Release"},{"key":"17927_CR32","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/jbm.a.34902","volume":"102","author":"DE Soranno","year":"2014","unstructured":"Soranno, D. E., Lu, H. D., Weber, H. M., Rai, R. & Burdick, J. A. Immunotherapy with injectable hydrogels to treat obstructive nephropathy. J Biomed Mater Res A \n                           102, 2173\u20132180, https:\/\/doi.org\/10.1002\/jbm.a.34902 (2014).","journal-title":"J Biomed Mater Res A"},{"key":"17927_CR33","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1128\/IAI.00047-11","volume":"79","author":"JC Cyktor","year":"2011","unstructured":"Cyktor, J. C. & Turner, J. Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect Immun \n                           79, 2964\u20132973, https:\/\/doi.org\/10.1128\/IAI.00047-11 (2011).","journal-title":"Infect Immun"},{"key":"17927_CR34","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI17459","volume":"111","author":"S Yamamoto","year":"2003","unstructured":"Yamamoto, S. et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. The Journal of clinical investigation \n                           111, 1463\u20131474, https:\/\/doi.org\/10.1172\/JCI17459 (2003).","journal-title":"The Journal of clinical investigation"},{"key":"17927_CR35","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10741-011-9279-6","volume":"17","author":"MK Szymanski","year":"2012","unstructured":"Szymanski, M. K., de Boer, R. A., Navis, G. J., van Gilst, W. H. & Hillege, H. L. Animal models of cardiorenal syndrome: a review. Heart Fail Rev \n                           17, 411\u2013420, https:\/\/doi.org\/10.1007\/s10741-011-9279-6 (2012).","journal-title":"Heart Fail Rev"},{"key":"17927_CR36","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1097\/01.ASN.0000145895.62896.98","volume":"15","author":"RP van Dokkum","year":"2004","unstructured":"van Dokkum, R. P. et al. Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction. J Am Soc Nephrol \n                           15, 3103\u20133110, https:\/\/doi.org\/10.1097\/01.ASN.0000145895.62896.98 (2004).","journal-title":"J Am Soc Nephrol"},{"key":"17927_CR37","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.ijcard.2012.12.065","volume":"168","author":"S Liu","year":"2013","unstructured":"Liu, S. et al. Subtotal nephrectomy accelerates pathological cardiac remodeling post-myocardial infarction: implications for cardiorenal syndrome. Int J Cardiol \n                           168, 1866\u20131880, https:\/\/doi.org\/10.1016\/j.ijcard.2012.12.065 (2013).","journal-title":"Int J Cardiol"},{"key":"17927_CR38","first-page":"H98","volume":"245","author":"TH Hostetter","year":"1983","unstructured":"Hostetter, T. H. et al. Cardiorenal hemodynamics and sodium excretion in rats with myocardial infarction. Am J Physiol \n                           245, H98\u2013103 (1983).","journal-title":"Am J Physiol"},{"key":"17927_CR39","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0008-6363(97)00242-3","volume":"37","author":"Q Feng","year":"1998","unstructured":"Feng, Q. Elevation of an endogenous inhibitor of nitric oxide synthesis in experimental congestive heart failure. Cardiovascular Research \n                           37, 667\u2013675, https:\/\/doi.org\/10.1016\/s0008-6363(97)00242-3 (1998).","journal-title":"Cardiovascular Research"},{"key":"17927_CR40","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/S0735-1097(86)80104-8","volume":"8","author":"H Drexler","year":"1986","unstructured":"Drexler, H. et al. Regional vascular adjustments during recovery from myocardial infarction in rats. J Am Coll Cardiol \n                           8, 134\u2013142 (1986).","journal-title":"J Am Coll Cardiol"},{"key":"17927_CR41","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1093\/ndt\/gfn233","volume":"23","author":"WA Windt","year":"2008","unstructured":"Windt, W. A. et al. Myocardial infarction does not further impair renal damage in 5\/6 nephrectomized rats. Nephrol Dial Transplant \n                           23, 3103\u20133110, https:\/\/doi.org\/10.1093\/ndt\/gfn233 (2008).","journal-title":"Nephrol Dial Transplant"},{"key":"17927_CR42","doi-asserted-by":"publisher","unstructured":"Gnanaraj, J. & Radhakrishnan, J. Cardio-renal syndrome. F1000Res \n                           5, https:\/\/doi.org\/10.12688\/f1000research.8004.1 (2016).","DOI":"10.12688\/f1000research.8004.1"},{"key":"17927_CR43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/S0008-6363(99)00274-6","volume":"45","author":"X-M Gao","year":"2000","unstructured":"Gao, X.-M., Dart, A. M., Dewar, E., Jennings, G. & Du, X.-J. Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice. Cardiovascular Research \n                           45, 330\u2013338, https:\/\/doi.org\/10.1016\/s0008-6363(99)00274-6 (2000).","journal-title":"Cardiovascular Research"},{"key":"17927_CR44","doi-asserted-by":"publisher","unstructured":"Giam, B. et al. N-acetylcysteine attenuates the development of cardiac fibrosis and remodeling in a mouse model of heart failure. Physiol Rep \n                           4, https:\/\/doi.org\/10.14814\/phy2.12757 (2016).","DOI":"10.14814\/phy2.12757"},{"key":"17927_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/01.CIR.101.1.71","volume":"101","author":"XJ Du","year":"2000","unstructured":"Du, X. J. et al. 2-Adrenergic Receptor Overexpression Exacerbates Development of Heart Failure After Aortic Stenosis. Circulation \n                           101, 71\u201377, https:\/\/doi.org\/10.1161\/01.cir.101.1.71 (2000).","journal-title":"Circulation"},{"key":"17927_CR46","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1111\/j.1523-1755.2004.00600.x","volume":"65","author":"SR Dunn","year":"2004","unstructured":"Dunn, S. R., Qi, Z., Bottinger, E. P., Breyer, M. D. & Sharma, K. Utility of endogenous creatinine clearance as a measure of renal function in mice. Kidney Int \n                           65, 1959\u20131967, https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00600.x (2004).","journal-title":"Kidney Int"},{"key":"17927_CR47","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1172\/JCI82592","volume":"126","author":"H Yu","year":"2016","unstructured":"Yu, H. et al. A role for genetic susceptibility in sporadic focal segmental glomerulosclerosis. The Journal of clinical investigation \n                           126, 1067\u20131078, https:\/\/doi.org\/10.1172\/JCI82592 (2016).","journal-title":"The Journal of clinical investigation"},{"key":"17927_CR48","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/CIRCHEARTFAILURE.110.960831","volume":"4","author":"PY Chu","year":"2011","unstructured":"Chu, P. Y. et al. CXCR4 antagonism attenuates the cardiorenal consequences of mineralocorticoid excess. Circulation. Heart failure \n                           4, 651\u2013658, https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.110.960831 (2011).","journal-title":"Circulation. Heart failure"},{"key":"17927_CR49","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2215\/CJN.05340610","volume":"6","author":"M Yu","year":"2011","unstructured":"Yu, M., Kim, Y. J. & Kang, D. H. Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress. Clin J Am Soc Nephrol \n                           6, 30\u201339, https:\/\/doi.org\/10.2215\/CJN.05340610 (2011).","journal-title":"Clin J Am Soc Nephrol"},{"key":"17927_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1152\/physiolgenomics.00083.2015","volume":"48","author":"FZ Marques","year":"2016","unstructured":"Marques, F. Z. et al. Telomere dynamics during aging in polygenic left ventricular hypertrophy. Physiol Genomics \n                           48, 42\u201349, https:\/\/doi.org\/10.1152\/physiolgenomics.00083.2015 (2016).","journal-title":"Physiol Genomics"},{"key":"17927_CR51","doi-asserted-by":"publisher","first-page":"e95462","DOI":"10.1371\/journal.pone.0095462","volume":"9","author":"IM Westra","year":"2014","unstructured":"Westra, I. M., Oosterhuis, D., Groothuis, G. M. & Olinga, P. The effect of antifibrotic drugs in rat precision-cut fibrotic liver slices. PLoS One \n                           9, e95462, https:\/\/doi.org\/10.1371\/journal.pone.0095462 (2014).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17927-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T16:42:33Z","timestamp":1671813753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17927-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["17927"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17927-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,18]]},"assertion":[{"value":"26 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17718"}}